Behind every sample is a patient and family awaiting a high-quality, timely result.
…which is why US LABS stays well ahead of emerging science. We are the nation’s esoteric oncology laboratory.The communities we serve expect us to be an innovation leader. And every day we deliver, with great accuracy, information connectivity and high speed. Whatever your role in the patient care continuum, the reliable services of US LABS will save you time and optimize your performance.
What's New
BreastOncPxTM: Can be used to estimate the likelihood of disease recurrence including distant metastasis in node-negative (N-), ER-positive (ER+) breast cancer patients.
KRAS and BRAF: Mutation status
has recently been shown to
provide prognostic and
potentially predictive information
for patients considered for
anti-EGFR monoclonal antibody
therapies.
PNH Evaluation by flow cytometry: High-sensitivity flow from US LABS
allows for detection of smaller
PNH clones than standard
flow cytometry. Events & Education
CAP 09
Gaylord National Hotel & Convention Center
Washington, DC
October 11 - 14
Join us for our dinner workshop on
Molecular Diagnostic Applications in Breast Cancer
Oct 12 @ 6 PM at the Gaylord National Hotel
Advanced registration is required, as space is limited.
Please register for this session online at CAP.org.
Use session code IWSD501 when registering.
